AUD 1.2
(-0.42%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 13.65 Million AUD | 4.99% |
2022 | 13 Million AUD | 2.62% |
2021 | 12.67 Million AUD | 13.57% |
2020 | 11.15 Million AUD | 19.68% |
2019 | 9.32 Million AUD | 43.0% |
2018 | 6.52 Million AUD | 6.41% |
2017 | 6.12 Million AUD | 55.01% |
2016 | 3.95 Million AUD | 14.96% |
2015 | 3.43 Million AUD | 7.29% |
2014 | 3.2 Million AUD | -40.08% |
2013 | 5.34 Million AUD | -11.56% |
2012 | 6.04 Million AUD | -9.58% |
2011 | 6.68 Million AUD | -20.15% |
2010 | 8.37 Million AUD | 46.54% |
2009 | 5.71 Million AUD | 3.47% |
2008 | 5.52 Million AUD | 51.95% |
2007 | 3.63 Million AUD | 0.0% |
2005 | 9.65 Million AUD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 16.54 Million AUD | 0.0% |
2023 Q4 | 13.65 Million AUD | 0.0% |
2023 Q2 | 14.37 Million AUD | 0.0% |
2023 FY | 13.65 Million AUD | 4.99% |
2022 Q4 | 13 Million AUD | 0.0% |
2022 Q2 | 12.29 Million AUD | 0.0% |
2022 FY | 13 Million AUD | 2.62% |
2021 Q2 | 10.03 Million AUD | 0.0% |
2021 FY | 12.67 Million AUD | 13.57% |
2021 Q4 | 12.67 Million AUD | 0.0% |
2020 FY | 11.15 Million AUD | 19.68% |
2020 Q4 | 11.15 Million AUD | 0.0% |
2020 Q2 | 11.3 Million AUD | 0.0% |
2019 Q2 | 11.07 Million AUD | 0.0% |
2019 Q4 | 9.32 Million AUD | 0.0% |
2019 FY | 9.32 Million AUD | 43.0% |
2018 FY | 6.52 Million AUD | 6.41% |
2018 Q2 | 5.04 Million AUD | 0.0% |
2018 Q4 | 6.52 Million AUD | 0.0% |
2017 Q2 | 4.2 Million AUD | 0.0% |
2017 FY | 6.12 Million AUD | 55.01% |
2017 Q4 | 6.12 Million AUD | 0.0% |
2016 FY | 3.95 Million AUD | 14.96% |
2016 Q4 | 3.95 Million AUD | 0.0% |
2016 Q2 | 3.83 Million AUD | 0.0% |
2015 FY | 3.43 Million AUD | 7.29% |
2015 Q4 | 3.43 Million AUD | 0.0% |
2015 Q2 | 3.65 Million AUD | 0.0% |
2014 Q4 | 3.2 Million AUD | 0.0% |
2014 Q2 | 3.95 Million AUD | 0.0% |
2014 FY | 3.2 Million AUD | -40.08% |
2013 FY | 5.34 Million AUD | -11.56% |
2013 Q2 | 5.57 Million AUD | 0.0% |
2013 Q4 | 5.34 Million AUD | 0.0% |
2012 FY | 6.04 Million AUD | -9.58% |
2012 Q4 | 6.04 Million AUD | 0.0% |
2011 FY | 6.68 Million AUD | -20.15% |
2011 Q4 | 6.68 Million AUD | 0.0% |
2010 Q4 | 8.37 Million AUD | 0.0% |
2010 FY | 8.37 Million AUD | 46.54% |
2009 FY | 5.71 Million AUD | 3.47% |
2009 Q4 | 5.71 Million AUD | 0.0% |
2008 FY | 5.52 Million AUD | 51.95% |
2008 Q4 | 5.52 Million AUD | 0.0% |
2007 Q4 | 3.63 Million AUD | 0.0% |
2007 FY | 3.63 Million AUD | 0.0% |
2005 FY | 9.65 Million AUD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
4DMedical Limited | 49.08 Million AUD | 72.184% |
Adherium Limited | 3.4 Million AUD | -300.812% |
Aroa Biosurgery Limited | 14.77 Million AUD | 7.605% |
Atomo Diagnostics Limited | 1.29 Million AUD | -954.912% |
Anteris Technologies Ltd | 17.03 Million AUD | 19.863% |
Control Bionics Limited | 2.75 Million AUD | -394.807% |
CardieX Limited | 8.56 Million AUD | -59.475% |
Compumedics Limited | 22.14 Million AUD | 38.348% |
Cochlear Limited | 904.6 Million AUD | 98.491% |
CleanSpace Holdings Limited | 6.94 Million AUD | -96.479% |
EMVision Medical Devices Ltd | 5.45 Million AUD | -150.285% |
Nova Eye Medical Limited | 8.55 Million AUD | -59.667% |
HeraMED Limited | 1.5 Million AUD | -806.724% |
Imricor Medical Systems, Inc. | 25 Million AUD | 45.391% |
ImpediMed Limited | 6.24 Million AUD | -118.72% |
InhaleRx Limited | 911.41 Thousand AUD | -1398.191% |
LBT Innovations Limited | 5.5 Million AUD | -147.907% |
Micro-X Limited | 12.63 Million AUD | -8.079% |
Neurotech International Limited | 314.69 Thousand AUD | -4238.974% |
OncoSil Medical Limited | 1.98 Million AUD | -588.938% |
PolyNovo Limited | 37.04 Million AUD | 63.138% |
Respiri Limited | 3.55 Million AUD | -284.209% |
SomnoMed Limited | 24.78 Million AUD | 44.897% |
Universal Biosensors, Inc. | 10.61 Million AUD | -28.666% |
Uscom Limited | 2.07 Million AUD | -558.51% |
Visioneering Technologies, Inc. | 2.76 Million AUD | -393.5% |